Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression.
Gerstner ER, McNamara MB, Norden AD, Lafrankie D, Wen PY. Gerstner ER, et al. Among authors: mcnamara mb. J Neurooncol. 2009 Aug;94(1):97-101. doi: 10.1007/s11060-009-9809-4. Epub 2009 Feb 17. J Neurooncol. 2009. PMID: 19221865
Bevacizumab salvage therapy following progression in high-grade glioma patients treated with VEGF receptor tyrosine kinase inhibitors.
Scott BJ, Quant EC, McNamara MB, Ryg PA, Batchelor TT, Wen PY. Scott BJ, et al. Among authors: mcnamara mb. Neuro Oncol. 2010 Jun;12(6):603-7. doi: 10.1093/neuonc/nop073. Epub 2010 Feb 14. Neuro Oncol. 2010. PMID: 20156808 Free PMC article. Clinical Trial.
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma.
Norden AD, Drappatz J, Muzikansky A, David K, Gerard M, McNamara MB, Phan P, Ross A, Kesari S, Wen PY. Norden AD, et al. Among authors: mcnamara mb. J Neurooncol. 2009 Apr;92(2):149-55. doi: 10.1007/s11060-008-9745-8. Epub 2008 Nov 29. J Neurooncol. 2009. PMID: 19043778